Microbial Sensitivity Tests

"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).

Descriptor ID	D008826
MeSH Number(s)	E01.370.225.875.595 E05.200.875.595 E05.337.550.400
Concept/Terms	Microbial Sensitivity Tests Microbial Sensitivity Tests Microbial Sensitivity Test Sensitivity Test, Microbial Sensitivity Tests, Microbial Test, Microbial Sensitivity Tests, Microbial Sensitivity Drug Sensitivity Assay, Microbial Antimicrobial Susceptibility Breakpoint Determination Antimicrobial Susceptibility Breakpoint Determination Breakpoint Determination, Antimicrobial Susceptibility Virus Drug Sensitivity Tests Virus Drug Sensitivity Tests Viral Drug Sensitivity Tests Breakpoint Determination, Antibacterial Susceptibility Breakpoint Determination, Antibacterial Susceptibility Antibacterial Susceptibility Breakpoint Determination Fungus Drug Sensitivity Tests Fungus Drug Sensitivity Tests Fungal Drug Sensitivity Tests Minimum Inhibitory Concentration Minimum Inhibitory Concentration Concentration, Minimum Inhibitory Concentrations, Minimum Inhibitory Inhibitory Concentration, Minimum Inhibitory Concentrations, Minimum Minimum Inhibitory Concentrations Antibiogram Antibiogram Antibiograms Bacterial Sensitivity Tests Bacterial Sensitivity Tests Tests, Bacterial Sensitivity Sensitivity Tests, Bacterial Test, Bacterial Sensitivity Bacterial Sensitivity Test Sensitivity Test, Bacterial

Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Microbiological Techniques [E01.370.225.875]
Microbial Sensitivity Tests [E01.370.225.875.595]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Microbiological Techniques [E05.200.875]
Microbial Sensitivity Tests [E05.200.875.595]
Evaluation Studies as Topic [E05.337]
Drug Evaluation, Preclinical [E05.337.550]
Microbial Sensitivity Tests [E05.337.550.400]

Below are MeSH descriptors whose meaning is related to "Microbial Sensitivity Tests".

Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.

Bar chart showing 282 publications over 22 distinct years, with a maximum of 22 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	12	12
2003	1	19	20
2004	0	12	12
2005	0	9	9
2006	0	8	8
2007	1	14	15
2008	4	17	21
2009	0	4	4
2010	2	13	15
2011	1	9	10
2012	0	12	12
2013	2	10	12
2014	0	15	15
2015	1	21	22
2016	2	15	17
2017	1	13	14
2018	1	13	14
2019	0	11	11
2020	0	13	13
2021	0	12	12
2022	0	9	9
2023	0	5	5

Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.

Wise MG, Karlowsky JA, Mohamed N, Kamat S, Sahm DF. In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021. Eur J Clin Microbiol Infect Dis. 2023 Sep; 42(9):1135-1143.

View in: PubMed
Karlowsky JA, Lob SH, Siddiqui F, Akrich B, DeRyke CA, Young K, Motyl MR, Hawser SP, Sahm DF. In vitro activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa collected from patients with bloodstream, intra-abdominal and urinary tract infections in Western Europe: SMART 2018-2020. J Med Microbiol. 2023 Feb; 72(2).

View in: PubMed
Lob SH, Hawser SP, Siddiqui F, Alekseeva I, DeRyke CA, Young K, Motyl MR, Sahm DF. Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland-SMART 2017-2020. Eur J Clin Microbiol Infect Dis. 2023 Mar; 42(3):365-370.

View in: PubMed
Humphries RM, Janssen H, Hey-Hadavi JH, Hackel M, Sahm D. Multidrug-resistant Gram-negative bacilli recovered from respiratory and blood specimens from adults: the ATLAS surveillance program in European hospitals, 2018-2020. Int J Antimicrob Agents. 2023 Feb; 61(2):106724.

View in: PubMed
Karlowsky JA, Hackel MA, Stone GG, Sahm DF. In Vitro Activity of Ceftibuten-Avibactam against ?-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0134622.

View in: PubMed
Karlowsky JA, Hackel MA, Wise MG, Six DA, Uehara T, Daigle DM, Cusick SM, Pevear DC, Moeck G, Sahm DF. In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0128122.

View in: PubMed
Karlowsky JA, Wise MG, Hackel MA, Pevear DC, Moeck G, Sahm DF. Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-?-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018-2020 Global Surveillance Collection. Antimicrob Agents Chemother. 2022 11 15; 66(11):e0093422.

View in: PubMed
Lob SH, Estabrook MA, DeRyke CA, Alekseeva I, Siddiqui F, Young K, Motyl MR, Sahm DF. Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa - Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020. Int J Infect Dis. 2022 Dec; 125:250-257.

View in: PubMed
Karlowsky JA, Lob SH, DeRyke CA, Hilbert DW, Wong MT, Young K, Siddiqui F, Motyl MR, Sahm DF. In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020. Antimicrob Agents Chemother. 2022 05 17; 66(5):e0018922.

View in: PubMed
Sun Z, Su L, Cotroneo N, Critchley I, Pucci M, Jain A, Palzkill T. Evaluation of Tebipenem Hydrolysis by ß-Lactamases Prevalent in Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2022 May 17; 66(5):e0239621.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement